Review Article
1 July 2026
• pp. Article 3
SGLT2 Inhibitors and GLP-1 Receptor Agonists in Cardiorenal-Metabolic Syndrome: Canadian Evidence, Mechanistic Complementarity, and Pharmacotherapeutic Strategies
MOHAMED ABDELLATIF